Stock Symbol 01177
About Us
About Sino Biopharm
Management Team
Major Events
R&D
Products
Innovative Products
Oncology
Hepatology
Respiratory
Surgery/Analgesic
Others
News
Sustainability
ESG Strategy and Governance
ESG Policies and Commitments
ESG Dynamics
ESG Reports
Investors
Information Disclosure
Corporate Governance
Presentation
Investor FAQs
Notices
Legel Terms
CN
EN
Investors
Home
>
Investors
>
Information Disclosure
Information Disclosure
Corporate Governance
Presentation
Investor FAQs
Notices
Information Disclosure
2018 ANNUAL REPORT
2019.04.29
2018 Interim Report
2018.09.18
2017 ANNUAL REPORT
2018.04.25
Interim Report 2017
2017.09.07
2016 ANNUAL REPORT
2017.04.27
2016 Interim Report
2016.09.22
2015 ANNUAL REPORT
2016.04.28
2015 Interim Report
2015.09.25
first page
previous page
51
52
53
54
55
56
...
60
last page
next page